FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

27294411000001105: Matoride XL 54mg tablets (Sandoz Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Oct 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
83769501000001116 Matoride XL 54mg tablets (Sandoz Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
83769601000001117 Matoride XL 54mg tablets (Sandoz Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Matoride XL 54mg tablets (Sandoz Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Matoride XL 54mg tablets (Sandoz Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Matoride XL 54mg tablets (Sandoz Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Matoride XL 54mg tablets (Sandoz Ltd) Is a Methylphenidate hydrochloride 54mg m/r tablet false Inferred relationship Existential restriction modifier
Matoride XL 54mg tablets (Sandoz Ltd) Has active ingredient Methylphenidate hydrochloride true Inferred relationship Existential restriction modifier
Matoride XL 54mg tablets (Sandoz Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Matoride XL 54mg tablets (Sandoz Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Matoride XL 54mg tablets (Sandoz Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Matoride XL 54mg tablets (Sandoz Ltd) Has specific active ingredient Methylphenidate hydrochloride true Inferred relationship Existential restriction modifier
Matoride XL 54mg tablets (Sandoz Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Matoride XL 54mg tablets (Sandoz Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Matoride XL 54mg tablets (Sandoz Ltd) Has excipient Butylated hydroxytoluene false Inferred relationship Existential restriction modifier
Matoride XL 54mg tablets (Sandoz Ltd) Is a Matoride XL true Inferred relationship Existential restriction modifier
Matoride XL 54mg tablets (Sandoz Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Matoride XL 54mg tablets (Sandoz Ltd) VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Matoride XL 54mg tablets (Sandoz Ltd) Is a Methylphenidate 54mg modified-release tablets false Inferred relationship Existential restriction modifier
Matoride XL 54mg tablets (Sandoz Ltd) Is a Methylphenidate 54mg modified-release tablets true Inferred relationship Existential restriction modifier
Matoride XL 54mg tablets (Sandoz Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Matoride XL 54mg tablets (Sandoz Ltd) 30 tablet Has AMP True Matoride XL 54mg tablets (Sandoz Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start